CORMEDIX INC. Inventory, Raw Materials, Gross
CORMEDIX INC. (CRMD) had Inventory, Raw Materials, Gross of $11.15 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:InventoryRawMaterials · last filed 2026-08-13
- 2026-06-30: Inventory, Raw Materials, Gross $11.15M.
- 2026-03-31: Inventory, Raw Materials, Gross $6.22M.
- 2025-12-31: Inventory, Raw Materials, Gross $3.63M.
- 2025-09-30: Inventory, Raw Materials, Gross $7.02M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $11.15M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $6.22M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.63M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.02M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.11M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.11M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.11M 10-K · filed 2026-03-05 | $1.11M 10-K · filed 2025-03-25 |
| 2024-09-30 | $603.54K 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $919.80K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.42M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.53M 10-K · filed 2025-03-25 | |
| 2020-03-31 | $6.89K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.89K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $6.89K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $6.89K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $6.89K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $71.28K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $93.72K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $93.72K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $140.69K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $141.23K 10-K · filed 2019-05-29 | |
| 2017-09-30 | $290.97K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $280.26K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $79.90K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $79.90K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $221.35K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $221.35K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $244.39K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $244.46K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $245.36K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $247.63K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $293.76K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $293.98K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $304.28K 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $77.10K 10-K · filed 2015-03-12 | |
| 2013-09-30 | $216.92K 10-Q/A · filed 2014-03-04 | |
| 2012-09-30 | $0.00 10-Q/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |